Evidence map›Paper›PMID 12242665›Full record

ArticleOncogene2002

PLZF induces megakaryocytic development, activates Tpo receptor expression and interacts with GATA1 protein.

Catherine Labbaye, Maria Teresa Quaranta, Alfredo Pagliuca, Stefania Militi, Jonathan D Licht, Ugo Testa, Cesare Peschle

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 61 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. SCL/TAL1-mediated transcriptional network enhances megakaryocytic specification of human embryonic stem cells.Molecular therapy : the journal of the American Society of Gene Therapy · 2015
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Catherine LabbayeDepartment of Hematology-Oncology, Istituto Superiore di Sanità, 00161 Rome, Italy. clabbaye@iss.it
Maria Teresa Quaranta
Alfredo Pagliuca
Stefania Militi
Jonathan D Licht
Ugo Testa
Cesare Peschle
Istituto Superiore di Sanità · ITIcahn School of Medicine at Mount Sinai · US

Funding

The PLZF Protein of t(11;17)-Promyelocytic LeukemiaR01CA059936 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI LICHT, JONATHAN · 1993 to 2007
$2.9M
NCI NIH HHS CA 59936
6 · The paper itself

Abstract

We investigated the expression of the PLZF gene in purified human hematopoietic progenitors induced to unilineage erythroid, granulocytic or megakaryocytic differentiation and maturation in serum-free culture. PLZF is expressed in quiescent progenitors: the expression level progressively rises through megakaryocytic development, whereas it gradually declines in erythroid and granulopoietic culture. To investigate the role of PLZF in megakaryopoiesis, we transduced the PLZF gene into the erythro-megakaryocytic TF1 cell line. PLZF overexpression upmodulates the megakaryocytic specific markers (CD42a, CD42b, CD61, PF4) and induces the thrombopoietin receptor (TpoR). The proximal promoter of the TpoR gene is activated in PLZF-expressing TF1 cells: in this promoter region, a PLZF DNA-binding site was identified by deletion constructs studies. Interestingly, PLZF and GATA1 proteins coimmunoprecipitate in PLZF-expressing TF1 cells: enforced expression of both PLZF and GATA1 in TF1 cells results in increased upregulation of megakaryocytic markers, as compared to exogenous PLZF or GATA1 alone, suggesting a functional role for the PLZF/GATA1 complex. Our data indicate that PLZF plays a significant stimulatory role in megakaryocytic development, seemingly mediated in part by induction of TpoR expression at transcriptional level. This stimulatory effect is potentiated by physical interaction of PLZF and GATA1, which are possibly assembled in a multiprotein transcriptional complex.

Indexed as

Neoplasm ProteinsReceptors, CytokineBinding SitesCell DifferentiationCell LineDNA-Binding ProteinsErythroid-Specific DNA-Binding FactorsGATA1 Transcription FactorHumansKruppel-Like Transcription FactorsMegakaryocytesPromoter Regions, GeneticPromyelocytic Leukemia Zinc Finger ProteinProto-Oncogene ProteinsReceptors, ThrombopoietinRNA, MessengerDNA-Binding ProteinsErythroid-Specific DNA-Binding FactorsGATA1 protein, humanGATA1 Transcription FactorKruppel-Like Transcription FactorsMPL protein, humanNeoplasm ProteinsPromyelocytic Leukemia Zinc Finger ProteinProto-Oncogene ProteinsReceptors, CytokineReceptors, ThrombopoietinRNA, MessengerTranscription FactorsZBTB16 protein, human

Identifiers

PMID12242665
OpenAlexW2073698793

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.